CoChat

Aging, Cellular Senescence, and Progressive Multiple Sclerosis

Open access
Papadopoulos, Dimitrios, Magliozzi, Roberta, Mitsikostas, Dimos D., Gorgoulis, Vassilis G., Nicholas, Richard S. · 2020 · Frontiers in Cellular Neuroscience
Cited by 79

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Aging is one of the most important risk factors for the development of several neurodegenerative diseases including progressive multiple sclerosis (MS). Cellular senescence (CS) is a key biological process underlying aging. Several stressors associated with aging and MS pathology, such as oxidative stress, mitochondrial dysfunction, cytokines and replicative exhaustion are known triggers of cellular senescence. Senescent cells exhibit stereotypical metabolic and functional changes, which include cell-cycle arrest and acquiring a pro-inflammatory phenotype secreting cytokines, growth factors, metalloproteinases and reactive oxygen species. They accumulate with aging and can convert neighboring cells to senescence in a paracrine manner. In MS, accelerated cellular senescence may drive disease progression by promoting chronic non-remitting inflammation, loss or altered immune, glial and neuronal function, failure of remyelination, impaired blood-brain barrier integrity and ultimately neurodegeneration. Here we discuss the evidence linking cellular senescence to the pathogenesis of MS and the putative role of senolytic and senomorphic agents as neuroprotective therapies in tackling disease progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fncel.2020.00178

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Research works printed but not linked: 71

  1. Al-Mashhadi, 2015, Oxidative glial cell damage associated with white matter lesions in the aging human brain, Brain Pathol, 25, 565, 10.1111/bpa.12216 · DOI · Paper page
  2. Ayad, 2018, Regulation of p38 mitogen-activated kinase-mediated fetal membrane senescence by statins, Am. J. Reprod. Immunol., 80, e12999, 10.1111/aji.12999 · DOI
  3. Barbouti, 2019, In situ evidence of cellular senescence in thymic epithelial cells (TECs) during human thymic involution, Mech. Ageing Dev, 177, 88, 10.1016/j.mad.2018.02.005 · DOI · Paper page
  4. Berthiaume, 2018, Pericyte structural remodeling in cerebrovascular health and homeostasis, Front. Aging Neurosci, 10, 210, 10.3389/fnagi.2018.00210 · DOI
  5. Bose, 2010, Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations, Cell Death Dis, 1, e92, 10.1038/cddis.2010.60 · DOI
  6. Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 · DOI · Paper page
  7. Broux, 2015, IL-15 amplifies the pathogenic properties of CD4+CD28− T cells in multiple sclerosis, J. Immunol, 194, 2099, 10.4049/jimmunol.1401547 · DOI
  8. Broux, 2012, CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients, J. Autoimmun., 38, 10, 10.1016/j.jaut.2011.11.006 · DOI
  9. Castellazzi, 2020, Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient, Fluids Barriers CNS, 17, 14, 10.1186/s12987-020-0173-2 · DOI
  10. Chang, 2008, Neurogenesis in the chronic lesions of multiple sclerosis, Brain, 131, 2366, 10.1093/brain/awn157 · DOI
  11. Chataway, 2014, Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial, Lancet, 383, 2213, 10.1016/S0140-6736(13)62242-4 · DOI · Paper page
  12. Christian, 2014, Functions and dysfunctions of adult hippocampal neurogenesis, Annu. Rev. Neurosci, 37, 243, 10.1146/annurev-neuro-071013-014134 · DOI · Paper page
  13. Claes, 2016, Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients, J. Immunol, 197, 4576, 10.4049/jimmunol.1502448 · DOI · Paper page
  14. Cole, 2020, Accelerated brain ageing and disability in multiple sclerosis, Ann Neurol, 10.1101/584888 · DOI
  15. Compston, 2008, Multiple sclerosis, Lancet, 372, 1502, 10.1016/S0140-6736(08)61620-7 · DOI · Paper page
  16. Danilov, 2006, Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis, Eur. J. Neurosci, 23, 394, 10.1111/j.1460-9568.2005.04563.x · DOI
  17. Davalos, 2012, Fibrinogen as a key regulator of inflammation in disease, Semin. Immunopathol, 34, 43, 10.1007/s00281-011-0290-8 · DOI · Paper page
  18. Davalos, 2012, Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation, Nat. Commun., 3, 1227, 10.1038/ncomms2230 · DOI · Paper page
  19. De Stefano, 2016, Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 87, 93, 10.1136/jnnp-2014-309903 · DOI · Paper page
  20. Ding, 2020, Waking up quiescent neural stem cells: molecular mechanisms and implications in neurodevelopmental disorders, PLoS Genet., 16, e1008653, 10.1371/journal.pgen.1008653 · DOI
  21. Elkjaer, 2019, Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis, Acta Neuropathol. Commun., 7, 205, 10.1186/s40478-019-0855-7 · DOI
  22. Filippi, 2013, Gray matter damage predicts the accumulation of disability 13 years later in MS, Neurology, 81, 1759, 10.1212/01.wnl.0000435551.90824.d0 · DOI · Paper page
  23. Filippi, 2012, Association between pathological and MRI findings in multiple sclerosis, Lancet Neurol., 11, 349, 10.1016/S1474-4422(12)70003-0 · DOI · Paper page
  24. Fisniku, 2008, Gray matter atrophy is related to long-term disability in multiple sclerosis: GM atrophy and disability in MS, Ann. Neurol., 64, 247, 10.1002/ana.21423 · DOI · Paper page
  25. Franklin, 2015, Glia disease and repair- Remyelination, Cold Spring Harb. Perspect. Biol, 7, 1, 10.1101/cshperspect.a020594 · DOI · Paper page
  26. Görg, 2015, Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy, Glia, 63, 37, 10.1002/glia.22731 · DOI
  27. Habib, 2020, Association between shorter leukocyte telomeres and multiple sclerosis, J. Neuroimmunol., 341, 577187, 10.1016/j.jneuroim.2020.577187 · DOI
  28. Haider, 2011, Oxidative damage in multiple sclerosis lesions, 134, 1914, 10.1093/brain/awr128 · DOI · Paper page
  29. Hampton, 2012, Focal immune-mediated white matter demyelination reveals an age associated increase in axonal vulnerability and decreased remyelination efficiency, Am. J. Pathol, 180, 1897, 10.1016/j.ajpath.2012.01.018 · DOI
  30. Hemmer, 2015, Role of the innate and adaptive immune responses in the course of multiple sclerosis, Lancet Neurol., 14, 406, 10.1016/S1474-4422(14)70305-9 · DOI · Paper page
  31. Høgestøl, 2019, Cross-sectional and longitudinal MRI brain scans reveal accelerated brain aging in multiple sclerosis, Front. Neurol., 10, 450, 10.3389/fneur.2019.00450 · DOI
  32. Hollands, 2017, Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer's disease by compromising hippocampal inhibition, Mol. Neurodegener, 12, 64, 10.1186/s13024-017-0207-7 · DOI · Paper page
  33. Horiuchi, 2012, Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro, Neurobiol. Aging, 33, 499, 10.1016/j.neurobiolaging.2010.05.007 · DOI
  34. Hou, 2018, Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype, Chem. Biol. Interact, 283, 75, 10.1016/j.cbi.2018.02.002 · DOI
  35. Hou, 2017, Ginsenoside Rg3 prevents oxidative stress-induced astrocytic senescence and ameliorates senescence paracrine effects on glioblastoma, Molecules., 22, 1516, 10.3390/molecules22091516 · DOI
  36. Ikeda, 2010, DNA damage detected with gammaH2AX in endometrioid adenocarcinoma cell lines, Int. J. Oncol., 36, 1081, 10.3892/ijo_00000589 · DOI
  37. Johansson, 1999, Neural stem cells in the adult human brain, Exp. Cell Res, 253, 733, 10.1006/excr.1999.4678 · DOI · Paper page
  38. Kirkwood, 2011, On the programmed/non-programmed nature of ageing within the life history, Curr. Biol, 21, R701, 10.1016/j.cub.2011.07.020 · DOI · Paper page
  39. Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol, 157, 267, 10.1016/S0002-9440(10)64537-3 · DOI · Paper page
  40. Krysko, 2019, Telomere length is associated with disability progression in multiple sclerosis, Ann. Neurol, 86, 671, 10.1002/ana.25592 · DOI
  41. Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
  42. Li, 2016, N-stearoyl-L-tyrosine inhibits the senescence of neural stem/progenitor cells induced by A1-42 via the CB2 receptor, Stem Cells Int., 2016, 7419389, 10.1155/2016/7419389 · DOI
  43. Lye, 2019, Astrocyte senescence may drive alterations in GFAPα, CDKN2A p14ARF, and TAU3 transcript expression and contribute to cognitive decline, Geroscience, 41, 561, 10.1007/s11357-019-00100-3 · DOI · Paper page
  44. Maeda, 2019, Potential of adult endogenous neural stem/progenitor cells in the spinal cord to contribute to remyelination in experimental autoimmune encephalomyelitis, Cells, 8, E1025, 10.3390/cells8091025 · DOI
  45. Mahmoudi, 2019, Turning back time with emerging rejuvenation strategies, Nat. Cell Biol, 21, 32, 10.1038/s41556-018-0206-0 · DOI · Paper page
  46. Martínez-Cué, 2020, cellular senescence in neurodegenerative diseases, Front. Cell. Neurosci., 14, 16, 10.3389/fncel.2020.00016 · DOI · Paper page
  47. Mei, 2016, Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery, Elife, 5, e13, 10.7554/eLife.18246.013 · doi:10.7554/elife.18246.013
  48. Mothe, 2005, Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat, Neuroscience, 131, 177, 10.1016/j.neuroscience.2004.10.011 · DOI · Paper page
  49. Nakamura, 2008, Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence, Epigenet. Chromatin, 1, 6, 10.1186/1756-8935-1-6 · DOI · Paper page
  50. Neumann, 2019, Metformin restores CNS remyelination capacity by rejuvenating aged stem cells, Cell. Stem Cell. 25, 473, 10.1016/j.stem.2019.08.015 · DOI · Paper page
  51. Nicaise, 2019, Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis, Proc. Natl. Acad. Sci. U.S.A, 116, 9030, 10.1073/pnas.1818348116 · DOI · Paper page
  52. Nie, 2015, 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces premature senescence of astrocytes via WNT/-catenin signaling and ROS production, J. Appl. Toxicol, 35, 851, 10.1002/jat.3084 · DOI · Paper page
  53. Oost, 2018, Targeting senescence to delay progression of multiple sclerosis, J. Mol. Med. (Berl)., 96, 1153, 10.1007/s00109-018-1686-x · DOI
  54. Papadopoulos, 2006, Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat, Exp. Neurol, 197, 373, 10.1016/j.expneurol.2005.10.033 · DOI · Paper page
  55. Pardo, 2017, The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations, J. Neurol, 264, 2351, 10.1007/s00415-017-8594-9 · DOI
  56. Patani, 2007, Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathol. Appl. Neurobiol., 33, 277, 10.1111/j.1365-2990.2007.00805.x · DOI · Paper page
  57. Pertusa, 2007, Astrocytes aged in vitro show a decreased neuroprotective capacity, J. Neurochem, 101, 794, 10.1111/j.1471-4159.2006.04369.x · DOI · Paper page
  58. Poulsen, 2014, Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence, Ann. Rheum. Dis, 73, 1405, 10.1136/annrheumdis-2012-203146 · DOI · Paper page
  59. Prozorovski, 2019, Regulation of sirtuin expression in autoimmune neuroinflammation: induction of SIRT1 in oligodendrocyte progenitor cells, Neurosci. Lett, 704, 116, 10.1016/j.neulet.2019.04.007 · DOI
  60. Rivera, 2019, Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination, Glia, 67, 1510, 10.1002/glia.23624 · DOI
  61. Shen, 2008, Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency, Nat. Neurosci, 11, 1024, 10.1038/nn.2172 · DOI · Paper page
  62. Sim, 2002, The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J. Neurosci., 22, 2451, 10.1523/JNEUROSCI.22-07-02451.2002 · DOI · Paper page
  63. Suh, 2009, Signaling in adult neurogenesis, Annu. Rev. Cell Dev. Biol, 25, 253, 10.1146/annurev.cellbio.042308.113256 · DOI · Paper page
  64. Tamanini, 2018, In vivo transient and partial cell reprogramming to pluripotency as a therapeutic tool for neurodegenerative diseases, Mol. Neurobiol., 55, 6850, 10.1007/s12035-018-0888-0 · DOI
  65. Thewissen, 2005, Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients, Ann. N. Y. Acad. Sci, 1051, 255, 10.1196/annals.1361.066 · DOI
  66. Thoppil, 2020, Senolytics: a translational bridge between cellular senescence and organismal aging, Front. Cell. Dev. Biol., 7, 367, 10.3389/fcell.2019.00367 · DOI
  67. Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502 · DOI · Paper page
  68. Weiss, 1996, Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis, J. Neurosci, 16, 7599, 10.1523/JNEUROSCI.16-23-07599.1996 · DOI · Paper page
  69. Weissert, 2013, The immune pathogenesis of multiple sclerosis, J. Neuroimmune Pharmacol, 8, 857, 10.1007/s11481-013-9467-3 · DOI
  70. Werner, 2001, Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage, Ann. Neurol., 50, 169, 10.1002/ana.1077 · DOI · Paper page
  71. Yabluchanskiy, 2020, Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation–induced impairment of neurovascular coupling responses protecting cognitive function in mice, Geroscience, 42, 409, 10.1007/s11357-020-00154-8 · DOI

Cited by

See all 79

Metadata

Authors
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S.
Venue
Frontiers in Cellular Neuroscience
Published
2020-06-30
Volume
14
Pages
178-178
ISSN
1662-5102 (ISSN-L)
OpenAlex
W3039523091
Cited by
79
References
79
FWCI
5.46
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aging, Cellular Senescence, and Progressive Multiple Sclerosis. https://app.cochat.ai/papers/10.3389/fncel.2020.00178
The paper
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020). Aging, Cellular Senescence, and Progressive Multiple Sclerosis. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2020.00178

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.